Apyx Medical Corporation
APYX
$0.958
$0.0788.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.00% | -4.08% | -10.47% | -15.63% | 16.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.00% | -4.08% | -10.47% | -15.63% | 16.26% |
| Cost of Revenue | -8.29% | 13.38% | 8.53% | -6.00% | 31.19% |
| Gross Profit | 0.39% | -12.84% | -19.25% | -21.44% | 8.35% |
| SG&A Expenses | -18.10% | -15.70% | -1.97% | -6.26% | 1.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.50% | -8.97% | 1.14% | -5.04% | 8.89% |
| Operating Income | 47.23% | 21.61% | -41.25% | -17.89% | 6.20% |
| Income Before Tax | 52.08% | 6.59% | -585.83% | -29.97% | -61.26% |
| Income Tax Expenses | 2.30% | 118.87% | -24.24% | 102.34% | -42.38% |
| Earnings from Continuing Operations | 51.59% | -1.05% | -546.32% | -114.89% | -58.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 82.35% | -54.35% | 20.00% | -71.43% | 6.25% |
| Net Income | 51.83% | -1.60% | -559.56% | -117.51% | -58.82% |
| EBIT | 47.23% | 21.61% | -41.25% | -17.89% | 6.20% |
| EBITDA | 48.33% | 21.57% | -42.77% | -19.42% | 5.57% |
| EPS Basic | 56.33% | -1.65% | -559.23% | -117.18% | -58.64% |
| Normalized Basic EPS | 36.24% | 5.97% | -79.72% | -31.27% | -4.98% |
| EPS Diluted | 56.33% | -1.65% | -559.23% | -117.18% | -58.64% |
| Normalized Diluted EPS | 36.24% | 5.97% | -79.72% | -31.27% | -4.98% |
| Average Basic Shares Outstanding | 10.31% | 0.01% | 0.12% | 0.13% | 0.14% |
| Average Diluted Shares Outstanding | 10.31% | 0.01% | 0.12% | 0.13% | 0.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
